Something significant happened in women's health this week. On May 12, 2026, a landmark paper published in The Lancet and presented at the European Congress of Endocrinology officially renamed Polycystic Ovary Syndrome. After more than a decade of advocacy and input from over 22,000 patients and clinicians across the globe, PCOS is now PMOS: Polyendocrine Metabolic Ovarian Syndrome.

It sounds like a technicality. It is anything but.

Why the Old Name Was a Problem

For decades, "Polycystic Ovary Syndrome" told a misleading story. It pointed to the ovaries and implied cysts, which led countless women and their providers to dismiss or delay a diagnosis when cysts weren't visible on imaging. The WHO estimates that 70% of people with this condition remain undiagnosed. Seventy percent.

The symptoms that actually drive quality of life for most women with PMOS aren't about cysts. They are about the entire body:

What Changed and What Didn't

The diagnostic criteria and treatment recommendations have not changed. If you were diagnosed with PCOS, that diagnosis still stands. The science underpinning your care is the same.

What has changed is the language that shapes how clinicians think and how patients understand their own bodies. This renaming came from a rigorous global consensus involving 56 leading academic, clinical, and patient organizations, with a transition roadmap that includes clinical guideline updates, medical education revisions, and international disease classification changes already in progress.

The name change opens doors: to more research funding, to broader clinical conversations, to providers who evaluate metabolic function rather than simply ordering a pelvic ultrasound and moving on.

Why This Matters for Your Care

At Navara Health TX, we have always believed that hormonal health cannot be understood through a single organ or a single symptom. PMOS, with its emphasis on endocrine complexity and metabolic health, is the framework we have been working within all along. Insulin resistance, cortisol, inflammation, body composition, sleep, nutrition: these are not supplementary considerations. They are the clinical core.

If you have spent years being dismissed because your ovaries looked "fine" on imaging, you were not wrong. Your symptoms were real. The name was the problem.

More educational content on PMOS, insulin resistance, hormone optimization, and women's metabolic health is coming. This is a conversation we are just getting started.